Efficacy of Selumetinib in Reducing Plexiform Neurofibroma Volume in Adults with Neurofibromatosis Type 1 By Ogkologos - July 1, 2025 514 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the KOMET study Source RELATED ARTICLESMORE FROM AUTHOR Noninferiority of OS with 3 Months Compared to 6 Months of Adjuvant Chemotherapy for Patients with High-Risk Stage III Colorectal Cancer Patient Guide on Bone Health in Cancer Now Available Also in French Lung Cancer Death Rates Among Women in Europe Are Finally Levelling Off MOST POPULAR Sustained PFS Benefit of Imlunestrant Over SoC in Patients with ESR1-mutated Advanced Breast Cancer December 19, 2025 Grace and Love for Full Hands March 31, 2021 Large DFS Benefit from Adjuvant Cemiplimab Among Patients at High Risk... June 18, 2025 FDA Grants Accelerated Approval to Tovorafenib for Patients with Relapsed or... May 2, 2024 Load more HOT NEWS Today is Random Acts of Kindness Day Mother and Son with Shared BRCA Gene Mutation Go Through Cancer... Got the COVID Blues? Darolutamide Delays the Spread of Some Prostate Cancers
